Skip to main content
. 2014 May 20;106(10):2134–2142. doi: 10.1016/j.bpj.2014.03.047

Figure 1.

Figure 1

Schematic representation of the designed peptides. K, KD, and S denote location of L-lysine, D-lysine, and L-serine, respectively. The remaining positions are occupied by L-glutamines, which are not denoted by letters, for greater clarity. The peptide shown in the scheme is PolyQKd-33. The peptide PolyQKd-32 has one less L-Gln in the middle section. The angles between β-strands indicated by dashed lines are arbitrary.